CTC Detection Rate in SCCHN With a in Vivo Device

N

Nanjing Tongren Hospital

Status

Unknown

Conditions

Squamous Cell Carcinoma of the Head and Neck
Circulating Tumor Cell

Treatments

Diagnostic Test: circulating tumor cell analysis

Study type

Interventional

Funder types

Other

Identifiers

NCT03071900
NJTRH_CellColletor01

Details and patient eligibility

About

Detection rate and isolation yield of CTC is low in squamous cell carcinoma of head and neck (SCCHN) with in vitro approaches rely on limited sample volumes. In this study, we applied a new method, the CellCollector, which could capture CTC in vivo from peripheral blood.

Enrollment

50 estimated patients

Sex

All

Ages

20 to 90 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • SCCHN confirmed with clinical examination
  • Have agreed to undergo CTC analysis in vivo;
  • ECOG:0-2

Exclusion criteria

the other cancer types

Trial design

50 participants in 2 patient groups

SCCHN
Experimental group
Description:
squamous cell carcinoma of the head and neck
Treatment:
Diagnostic Test: circulating tumor cell analysis
Control
Experimental group
Description:
health volunteers
Treatment:
Diagnostic Test: circulating tumor cell analysis

Trial contacts and locations

0

Loading...

Central trial contact

Zhenkun Yu, PhD; Haidong Zhang, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems